As SARS-CoV-2 is highly sensitive to the antiviral action of IFN-I [24], the upregulation of the IFN response in the airway tracts of CF patients might be involved in mediating protection against SARS-CoV-2 infection. Here, IFNA1 is linked to cystic fibrosis.